Skip to content
Company Analysis

Alcon Inc. ALC

A comprehensive view of key metrics, scores, and financial health for Alcon Inc.

Overview of Alcon Inc.

ALC NYQ
Healthcare Medical Instruments & Supplies Framework: Medical Devices & Diagnostics Large Cap
Alcon Inc. (ALC), is a Large Cap company, in the Medical Instruments & Supplies industry, last closed at $73.63, about 52.6% overvalued vs fair value, -0.9% 1Y return, ranked 302/1145 in sector.
Metrics P/E 39.9× Rev Growth 4.9% ROE 4.5% Gross Margin 55.2% Div Yield 0.42%
USD 73.63
3.05%
(Delayed)
• Vol 90d: 26.4%
52-Week Range
Market Cap
$35.65B
Enterprise Value
$39.01B
Overall Score
View breakdown
Overall
Growth
Good
Profitability
Good
Health
Fair
Efficiency
Fair
Valuation
Fair
Growth
Good
Profitability
Good
Health
Fair
Efficiency
Fair
Valuation
Fair
Completeness: 94%
Confidence: 95%
Updated: Oct 31
Top Beats
No strong beats yet

Quick Facts

Website https://www.alcon.com
HQ Geneva
Employees 25,942
Fiscal year Dec 31

Next Events

Earnings Nov 10 Call: Nov 11

Fair Value Snapshot

Bear Base Bull
$31
$35
$39
Current: $73.63 -53% vs base

Engine Room Money Flow™

Large Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$10.4B
4.9%%
Gross Profit
$5.7B
4.2%%
Operating Income (GAAP)
$1.4B
-3.8%%
EBITDA
$2.7B
0.9%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

Gross Margin
55.2%
Good

Gross Profit / Revenue — primary moat signal for MedTech. ≥65% indicates IP-protected consumables with strong pricing power.

Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium
Locked Metric
-
Premium

Owner's Pocket - Capital Allocation

Total Returned to Shareholders

Combined dividends, buybacks, and debt reduction

$842.0M
52.4% of Free Cash Flow

Where It Leaks

Cash Flow Health healthy
Strong cash conversion with minimal leakage across profit-to-cash-to-value chain.
0
Active Leaks
0/0
Improving
0
High Impact
0
Critical
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Alcon Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
73
/100
Moderate
Scores based on quantitative metrics and qualitative factors
Full moat analysis

Key strengths

  • Strong FCF Generation FCF margin quality is top-tier vs peers (score 0.87). High FCF conversion confirms strong earnings quality.
  • Strong Operating Margin vs Peers Operating margin level is strong vs peers (score 0.78). SG&A discipline is converting gross margin into operating profit efficiently.

The dashed ring is the peer median. Defense scores are percentile ranks against peers, so 50 is roughly the typical company in this group.

Upgrade to unlock the signals and evidence behind each defense.

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Strong
75
Premium

Signals, strengths and risks for Pricing Power & Consumable Moat

Premium

Signals, strengths and risks for R&D Pipeline & Capital Returns

Premium

Signals, strengths and risks for FCF Quality & Cash Conversion

Premium

Signals, strengths and risks for Commercial Execution

Premium

Signals, strengths and risks for Capital Structure & Resilience

Premium

Signals, strengths and risks for Growth Durability

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 100% Coverage
Trade-Off Triangle Visualization A ternary plot showing ALC's balance between Growth (26.7%), Profitability (39.1%), and Safety (34.2%). Growth 27% Safety 34% Profitability 39%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

50th percentile vs peers
50
Key Signals
EPS CAGR 3Y 42.9% 88p Rev Growth YoY 4.9% 44p Revenue CAGR 3Y 6.1% 48p EPS Growth YoY -3.5% 30p TSR -6.8% 49p
Strengths
  • EPS CAGR 3Y in top 20% of peers (42.9%, 88th percentile)
  • FCF Margin in top 20% of peers (15.5%, 87th percentile)
  • Operating Margin in top 20% of peers (13.1%, 82th percentile)
  • Interest Coverage (EBITDA) in top 20% of peers (13.23, 83th percentile)
  • Cash Flow to Debt Ratio in top 20% of peers (1.44, 84th percentile)
Risks

No significant risks identified for this axis.

Profitability

73th percentile vs peers
74
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

64th percentile vs peers
65
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Alcon Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
$34.89
- - -
-52.6% vs current
Snapshot base estimate
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000